Abbott has developed diagnostic solutions which it is showcasing this week during the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo in Chicago. During the AACC meeting, Abbott is featuring a variety of innovations focused on increased testing volumes and improving efficiencies:
- Core Laboratory: Abbott recently launched a next generation automation solution, the ACCELERATOR a3600, which doubles per-hour processing capacity compared to previous systems. By partnering with Abbott, studies have shown a core lab can eliminate a significant percentage of associated operating costs through automation and standardization of testing.
- Molecular: Abbott's m2000 RealTime System for automated infectious disease molecular testing gives labs the ability to handle greater volumes at reduced costs on a single platform. Labs that use Abbott's molecular automated solutions may process the same number of tests with fewer instruments.
- Point of Care: Used at a patient's bedside, the i-STAT System allows physicians and nurses to quickly and accurately analyze lab-quality results within minutes, rather than hours, to accelerate decision-making and ensure patients receive the most effective and efficient care.
“Abbott is designing the next generation of diagnostics solutions to help health care providers achieve faster and more accurate test results,” says Brian Blaser, executive vice president, Diagnostics Products, Abbott. “Abbott is focused on providing an integrated diagnostic solution, powered by innovations that can help our customers channel change into growth and ensure exceptional performance.” Read more about Abbott's presentations, posters and workshops during the AACC.
Read more
